There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: Results of a pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 5, 1999, Pages 959-964

  Mandell, Lynda R ^a   Kadota, Richard ^b   Freeman, Carolyn ^c   Douglass, Edwin C ^d   Fontanesi, James ^e   Cohen, Michael E ^f   Kovnar, Edward ^g   Burger, Peter ^h   Sanford, Robert A ⁱ   Kepner, James ^j   Friedman, Henry ^k   Kun, Larry E ^l  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d ASTRAZENECA   (United Kingdom)

^e HARPER UNIVERSITY HOSPITAL   (United States)

^f CHILDREN S HOSPITAL OF BUFFALO   (United States)

^g Midwest Athletes Against Childhood Cancer Inc   (United States)

^h JOHNS HOPKINS HOSPITAL   (United States)

ⁱ SEMMES MURPHEY NEUROLOGIC AND SPINE INSTITUTE   (United States)

^j UNIVERSITY OF FLORIDA   (United States)

^k DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

Brainstem tumors; Hyperfractionated radiotherapy; Radiotherapy

Indexed keywords

CISPLATIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN STEM TUMOR; CANCER GROWTH; CANCER SURVIVAL; CHILD; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOSENSITIZATION; TOXICITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; BRAIN STEM; CHILD; CHILD, PRESCHOOL; DOSE FRACTIONATION; FEMALE; GLIOMA; HUMANS; MALE; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032936059     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00501-X     Document Type: Article

References (35)

1. Reigel D.H., Scarff T.B., Woodford J.E. Biopsy of pediatric brain stem tumors. Childs Brain. 5:1979;329-340.
2. Lee F. Radiation of infratentorial and supratentorial brainstem tumors. J Neurosurg. 43:1975;65-68.
3. Halperin E.C. Pediatric brain stem tumors Patterns of treatment failure and their implications for radiotherapy . Int J Radiat Oncol Biol Phys. 11:1985;1293-1298.
4. Littman P., Jarret P., Bilaniuk L.T., et al. Pediatric brainstem gliomas. Cancer. 45:1980;2787-2792.
5. Eifel P.J., Cassady J.R., Belli J.A. Radiation therapy of tumors of the brainstem and midbrain in children Experience of the Joint Center for Radiation Therapy and Children's Hospital Medical Center (1971-1981) . Int J Radiat Oncol Biol Phys. 13:1987;847-852.
6. Freeman C.R., Suissa S. Brain stem tumors in children Results of a survey of 62 patients treated with radiotherapy . Int J Radiat Oncol Biol Phys. 12:1986;1823-1828.
7. Levin V.A., Edwards M.S.B., Wara W.M., et al. 5-Fluorouracil and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) followed by hydroxyurea, misonidazole, and irradiation for brain stem gliomas A pilot study of the Brain Tumor Research Center and Children's Cancer Group . Neurosurg. 14:1984;679-681.
8. Mantravadi R.V.P., Phatak R., Bellur S., et al. Brainstem gliomas An autopsy study of 25 cases . Cancer. 49:1982;1294-1296.
9. Salazar O.M., Rubin P., Feldstein M.L., et al. High dose radiation therapy in the treatment of malignant gliomas Final report . Int J Radiat Oncol Biol Phys. 5:1979;1733-1740.
10. Walker M.D., Strike T.A., Sheline G.E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 5:1979;1725-1731.
11. Freeman C.R., Krischer J.P., Sanford R.A., et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children A Pediatric Oncology Group study . Int J Radiat Oncol Biol Phys. 27:1993;197-206.
12. Packer R.J., Boyett J.M., Zimmerman R.A., et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy A Childrens Cancer Group Phase I/II trial . Cancer. 74:1994;1827-1834.
13. Prados M.D., Wara W.M., Edwards M.S.B., et al. The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys. 32:1995;85-91.
14. Freeman C.R., Krischer J., Sanford R.A., et al. Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group Study #8495. Cancer. 68:1991;474-481.
15. Packer R.J., Littman P.A., Sposto R.M., et al. Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomas. Int J Radiat Oncol Biol Phys. 13:1987;1647-1651.
16. Freeman C.R., Krischer J., Sanford R.A., et al. Hyperfractionated radiotherapy in brain stem tumors Results of a Pediatric Oncology Group Study . Int J Radiat Oncol Biol Phys. 15:1988;311-318.
17. Douple E.B. Keynote address Platinum-radiation interactions . NCI Monogr. 6:1988;315-319.
18. Coughlin C.T., Richmond R.C. Biologic and clinical developments of cisplatin combined with radiation. Semin Oncol. 16:1989;31-43.
19. Dewit L. Combined treatment of radiation and cisdiamminedicholoroplatinum (II) A review of experimental and clinical data . Int J Radiat Oncol Biol Phys. 13:1987;403-442.
20. Kanazawa H., Rappacchietta D., Kallman R.F. Schedule-dependent therapeutic gain from the combination of fractionated irradiation and cisdiamminedicholoroplatinum II in C3H/Km mouse model systems. Cancer Res. 48:1988;3158-3164.
21. Tanabe M., Godat D., Kallman R.F. Effects of fractionated schedules of irradiation combined with cis-diamminedicholoroplatinum II on the SCCVII/ST tumor and normal tissues of the C3H/KM mouse. Int J Radiat Oncol Biol Phys. 13:1987;1523-1532.
22. Lelieveld P., Scoles M.A., Brown J.M., et al. The effect of treatment in fractionated schedules with the combination of x-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin. Int J Radiat Oncol Biol Phys. 11:1985;1111-1121.
23. Vokes E., Weichelsbaum R.R. Concomitant chemoradiotherapy Rationale and clinical experience in patients with solid tumors . J Clin Oncol. 8:1990;911-934.
24. Salem P., Khalyl M., Jabboury K., et al. Cisdiamminedicholoroplatinum (II) by 5-day infusion. Cancer. 53:1984;837-840.
25. Posner M.R., Ferrari L., Belliveau J.F., et al. A phase I trial of continuous infusion cisplatin. Cancer. 59:1987;1518.
26. Castello M., Dominic C., Clerico A. A pilot study of 5-day continuous infusion cisplatin and pulsed etoposide in childhood solid tumors. Am J Pediatr Hematol Oncol. 10:1988;103-108.
27. Kadota R.P., Mandell L., Fontanesi J., et al. Hyperfractionated irradiation and concurrent cisplatin in brainstem tumors A Pediatric Oncology Group pilot study (9139) . Ped Neurosurg. 20:1994;221-225.
28. Fleming T.R., Harrington D.P., O'Brien P.C. Designs for group sequential tests. Contr Clin Trials. 5:1984;348-361.
29. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
30. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
31. Withers H.R. Biological basis for altered fractionated schemes. Cancer. 55:1985;2086-2095.
32. Thames H.R.D., Withers H.R.R., Peters L.J., et al. Changes in early and late radiation responses with altered dose fractionation Implications for dose-survival relationships . Int J Radiat Oncol Biol Phys. 8:1982;219-226.
33. Packer R.J., Allen J.C., Goldwein J.L., et al. Hyperfractionated radiotherapy for children with brainstem gliomas A pilot study using 7,200 cGy . Ann Neurol. 27:1990;167-173.
34. Edwards M.S.B., Wara W.M., Urtasun R.C., et al. Hyperfractionated radiation therapy for brain-stem glioma A phase I-II trial . J Neurosurg. 70:1989;691-700.
35. Freeman C.R., Bourgouin P.M., Sanford R.A., et al. Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy Clinical characteristics and treatment related toxicities . Cancer. 77:(3):1996;555-562.